1.Over-expression of extracellular superoxide dismutase in mouse synovial tissue attenuates the inflammatory arthritis.
Dong Hoon YU ; Jun Koo YI ; Hyung Soo YUH ; Seo jin PARK ; Hei Jung KIM ; Ki Beom BAE ; Young Rae JI ; Na Ri KIM ; Si Jun PARK ; Do Hyung KIM ; Sung Hyun KIM ; Myoung Ok KIM ; Jeong Woong LEE ; Zae Young RYOO
Experimental & Molecular Medicine 2012;44(9):529-535
Oxidative stress such as reactive oxygen species (ROS) within the inflamed joint have been indicated as being involved as inflammatory mediators in the induction of arthritis. Correlations between extracellular-superoxide dismutase (EC-SOD) and inflammatory arthritis have been shown in several animal models of RA. However, there is a question whether the over-expression of EC-SOD on arthritic joint also could suppress the progression of disease or not. In the present study, the effect on the synovial tissue of experimental arthritis was investigated using EC-SOD over-expressing transgenic mice. The over-expression of EC-SOD in joint tissue was confirmed by RT-PCR and immunohistochemistry. The degree of the inflammation in EC-SOD transgenic mice was suppressed in the collagen-induced arthritis model. In a cytokine assay, the production of pro-inflammatory cytokines such as, IL-1beta, TNFalpha, and matrix metalloproteinases (MMPs) was decreased in fibroblast-like synoviocyte (FLS) but not in peripheral blood. Histological examination also showed repressed cartilage destruction and bone in EC-SOD transgenic mice. In conclusion, these data suggest that the over-expression of EC-SOD in FLS contributes to the activation of FLS and protection from joint destruction by depressing the production of the pro-inflammatory cytokines and MMPs. These results provide EC-SOD transgenic mice with a useful animal model for inflammatory arthritis research.
Animals
;
Arthritis, Experimental/blood/*enzymology/metabolism
;
*Arthritis, Rheumatoid/enzymology/pathology
;
Fibroblasts/metabolism
;
Gene Expression Regulation
;
Inflammation/pathology
;
Interleukin-1beta/blood/metabolism
;
Joints/enzymology/pathology
;
Matrix Metalloproteinases/blood/metabolism
;
Mice
;
Mice, Transgenic
;
Reactive Oxygen Species/metabolism
;
*Superoxide Dismutase/genetics/metabolism
;
Synovial Fluid/*enzymology
;
Synovial Membrane/pathology
2.Rebamipide-induced downregulation of phospholipase D inhibits inflammation and proliferation in gastric cancer cells.
Dong Woo KANG ; Gyesik MIN ; Do Yoon PARK ; Ki Whan HONG ; Do Sik MIN
Experimental & Molecular Medicine 2010;42(8):555-564
Rebamipide a gastroprotective drug, is clinically used for the treatment of gastric ulcers and gastritis, but its actions on gastric cancer are not clearly understood. Phospholipase D (PLD) is overexpressed in various types of cancer tissues and has been implicated as a critical factor in inflammation and carcinogenesis. However, whether rebamipide is involved in the regulation of PLD in gastric cancer cells is not known. In this study, we showed that rebamipide significantly suppressed the expression of both PLD1 and PLD2 at a transcriptional level in AGS and MKN-1 gastric cancer cells. Downregulation of PLD expression by rebamipide inhibited its enzymatic activity. In addition, rebamipide inhibited the transactivation of nuclear factor kappa B (NFkappaB), which increased PLD1 expression. Rebamipide or PLD knockdown significantly suppressed the expression of genes involved in inflammation and proliferation and inhibited the proliferation of gastric cancer cells. In conclusion, rebamipide-induced downregulation of PLD may contribute to the inhibition of inflammation and proliferation in gastric cancer.
Alanine/*analogs & derivatives/pharmacology
;
Cell Line, Tumor
;
Cell Proliferation/drug effects
;
Down-Regulation/*drug effects
;
Gene Expression Regulation, Neoplastic/*drug effects
;
Humans
;
Inflammation/*enzymology/genetics/pathology
;
Isoenzymes/genetics/metabolism
;
NF-kappa B/metabolism
;
Phospholipase D/*genetics/metabolism
;
Promoter Regions, Genetic/genetics
;
Quinolones/*pharmacology
;
Stomach Neoplasms/*enzymology/genetics/*pathology
;
Transcription, Genetic/drug effects
3.Sphingomyelin synthase 2 deficiency decreases atherosclerosis and inhibits inflammation in mice.
Rui QIN ; Ming-Liang CHEN ; Ke ZHU ; Jin-Bo DENG ; Yuan-Yuan SHI
Acta Physiologica Sinica 2010;62(4):333-338
Plasma sphingomyelin (SM) has been shown to be an independent risk factor for coronary heart disease, and sphingomyelin synthase 2 (SMS2) contributes to de novo SM biosynthesis and plasma membrane SM levels. The aim of the present study is to evaluate the in vivo role of SMS2 deficiency in serum SM metabolism and atherosclerosis (AS) development. We used male SMS2 knockout (SMS2(-/-)) and C57BL/6J (wild-type, WT) mice as experimental and control groups, respectively. Each group was fed high-fat diet (1% cholesterol, 20% leaf fat), as well as bile salt for accelerating the atherosclerotic formation. After three months of feeding, the mice were killed to observe aortic arches and oil red-stained longitudinal sections of thoracoabdominal aortae. Fasting blood samples were taken from the tail vein before and after high-fat diet, and the serum lipid and SM levels were measured by using kits and enzymatic method respectively. Western blot was used to analyze the contents of nuclear factor-kappaB (NFkappaB) p65 subunit in peritoneal macrophages stimulated with lipopolysaccharide (LPS) after high-fat diet. The results showed that after high-fat diet, SMS2(-/-) mice presented decreased atherosclerotic lesions in aortic arch and thoracoabdominal aorta compared with WT mice. Regardless of whether high-fat diet were given or not, SMS2(-/-) mice showed a significant decrease in serum SM level (P<0.05), but no significant changes in serum lipid levels, compared with WT mice. The expressions of NFkappaB p65 were attenuated in macrophages from SMS2(-/-) mice in response to LPS stimulation compared with those of the WT mice. These results suggest that SMS2 deficiency decreases AS and inhibits inflammation in mice. Thus, SMS2 deficiency may be a potential therapeutic strategy.
Animals
;
Aorta
;
pathology
;
Atherosclerosis
;
metabolism
;
physiopathology
;
prevention & control
;
Diet, High-Fat
;
Dietary Fats
;
administration & dosage
;
Gene Knockout Techniques
;
Inflammation
;
prevention & control
;
Macrophages, Peritoneal
;
enzymology
;
pathology
;
Male
;
Mice
;
Mice, Inbred C57BL
;
Mice, Knockout
;
NF-kappa B
;
metabolism
;
Sphingomyelins
;
blood
;
Transferases (Other Substituted Phosphate Groups)
;
genetics
4.Pilea umbrosa ameliorate CCl induced hepatic injuries by regulating endoplasmic reticulum stress, pro-inflammatory and fibrosis genes in rat.
Irum NAZ ; Muhammad Rashid KHAN ; Jawaid Ahmed ZAI ; Riffat BATOOL ; Zartash ZAHRA ; Aemin TAHIR
Environmental Health and Preventive Medicine 2020;25(1):53-53
BACKGROUND:
Pilea umbrosa (Urticaceae) is used by local communities (district Abbotabad) for liver disorders, as anticancer, in rheumatism and in skin disorders.
METHODS:
Methanol extract of P. umbrosa (PUM) was investigated for the presence of polyphenolic constituents by HPLC-DAD analysis. PUM (150 mg/kg and 300 mg/kg) was administered on alternate days for eight weeks in rats exposed with carbon tetrachloride (CCl). Serum analysis was performed for liver function tests while in liver tissues level of antioxidant enzymes and biochemical markers were also studied. In addition, semi quantitative estimation of antioxidant genes, endoplasmic reticulum (ER) induced stress markers, pro-inflammatory cytokines and fibrosis related genes were carried out on liver tissues by RT-PCR analysis. Liver tissues were also studied for histopathological injuries.
RESULTS:
Level of antioxidant enzymes such as catalase (CAT), superoxide dismutase (SOD), peroxidase (POD) and glutathione (GSH) decreased (p < 0.05) whereas level of thiobarbituric acid reactive substance (TBARS), HO and nitrite increased in liver tissues of CCl treated rat. Likewise increase in the level of serum markers; alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP) and total bilirubin was observed. Moreover, CCl caused many fold increase in expression of ER stress markers; glucose regulated protein (GRP-78), x-box binding protein1-total (XBP-1 t), x-box binding protein1-unspliced (XBP-1 u) and x-box binding protein1-spliced (XBP-1 s). The level of inflammatory mediators such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1) was aggregated whereas suppressed the level of antioxidant enzymes; γ-glutamylcysteine ligase (GCLC), protein disulfide isomerase (PDI) and nuclear erythroid 2 p45-related factor 2 (Nrf-2). Additionally, level of fibrosis markers; transforming growth factor-β (TGF-β), Smad-3 and collagen type 1 (Col1-α) increased with CCl induced liver toxicity. Histopathological scrutiny depicted damaged liver cells, neutrophils infiltration and dilated sinusoids in CCl intoxicated rats. PUM was enriched with rutin, catechin, caffeic acid and apigenin as evidenced by HPLC analysis. Simultaneous administration of PUM and CCl in rats retrieved the normal expression of these markers and prevented hepatic injuries.
CONCLUSION
Collectively these results suggest that PUM constituted of strong antioxidant chemicals and could be a potential therapeutic agent for stress related liver disorders.
Animals
;
Carbon Tetrachloride
;
adverse effects
;
Chemical and Drug Induced Liver Injury
;
drug therapy
;
etiology
;
pathology
;
Endoplasmic Reticulum Stress
;
drug effects
;
Fibrosis
;
drug therapy
;
genetics
;
Inflammation
;
drug therapy
;
genetics
;
Liver
;
drug effects
;
enzymology
;
metabolism
;
Male
;
Protective Agents
;
pharmacology
;
Rats
;
Rats, Sprague-Dawley
;
Urticaceae
;
chemistry